Lantheus Medical Imaging Initiates Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease Read more about Lantheus Medical Imaging Initiates Phase 3 Clinical Trial of Flurpiridaz F 18 for the Detection of Coronary Artery Disease
Lantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference Read more about Lantheus Medical Imaging to Present at Jefferies 2011 Global Healthcare Conference
Lantheus Medical Imaging to Present Data on Novel PET Cardiac and Heart Failure Imaging Agents at SNM 58th Annual Meeting Read more about Lantheus Medical Imaging to Present Data on Novel PET Cardiac and Heart Failure Imaging Agents at SNM 58th Annual Meeting
Lantheus Medical Imaging to Present Phase 2 Data of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at the International Conference of Non-Invasive Cardiovascular Imaging Read more about Lantheus Medical Imaging to Present Phase 2 Data of PET Myocardial Perfusion Imaging with Flurpiridaz F 18 at the International Conference of Non-Invasive Cardiovascular Imaging
Lantheus Medical Imaging Presents Phase 2 Study Results of PET Myocardial Perfusion Read more about Lantheus Medical Imaging Presents Phase 2 Study Results of PET Myocardial Perfusion
Lantheus Medical Imaging to Host First Quarter 2011 Conference Call Read more about Lantheus Medical Imaging to Host First Quarter 2011 Conference Call
Lantheus Medical Imaging Presents Promising Results of Latest Safety Studies Read more about Lantheus Medical Imaging Presents Promising Results of Latest Safety Studies
Lantheus Medical Imaging Commences Exchange Offer Read more about Lantheus Medical Imaging Commences Exchange Offer
Lantheus Medical Imaging Announces Completion of Exchange Offer for its 9.750% Senior Notes Due 2017 Read more about Lantheus Medical Imaging Announces Completion of Exchange Offer for its 9.750% Senior Notes Due 2017
Lantheus Medical Imaging Commences Consent Solicitation Read more about Lantheus Medical Imaging Commences Consent Solicitation
